EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA

Eduardo Magalhães Rego; Rafael Henriques Jácomo

doi:10.4084/mjhid.2011.049

Mediterranean Journal of Hematology and Infectious Diseases (Oct 2011)

EPIDEMIOLOGY AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN LATIN AMERICA

Eduardo Magalhães Rego,
Rafael Henriques Jácomo

Affiliations

Eduardo Magalhães Rego: National Institute of Science and Technology in Stem Cell and Cell Therapy, Division of Oncology/Hematology, Department of Internal Medicine, Medical School of Ribeirão Preto, University of São Paulo,
Rafael Henriques Jácomo: Department of Internal Medicine, Medical School, University of Brasília, Brazil

DOI: https://doi.org/10.4084/mjhid.2011.049
Journal volume & issue: Vol. 3, no. 1
pp. e2011049 – e2011049

Abstract

Read online

Distinct epidemiological characteristics have been described in Acute Promielocytic Leukemia (APL). Populations from Latin America have a higher incidence of APL and in some geographic areas a distinct distribution of the PML-RARA isoforms is present. Here, we review the main differences in APL epidemilogy in Latin America as well as treatment outcomes.

Leukemia, Acute Promylocytic Leukemia, Latin America, Epidemiology

Published in Mediterranean Journal of Hematology and Infectious Diseases

ISSN: 2035-3006 (Online)
Publisher: PAGEPress Publications
Country of publisher: Italy
LCC subjects: Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
Website: http://www.mjhid.org/

About the journal

Abstract

Keywords